Ilya A. Bykov

Ilya A. Bykov

Auto-generated profile, based on publicly available information

Ilya A. Bykov

Far Eastern State Medical University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2019 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
JLJingjing Liu
Jingjing Liu
HYHui Yin
Hui Yin
TZTong Zheng
Tong Zheng
BIBykov Ilia
Bykov Ilia
XWXing Wang
Xing Wang
QWQunhong Wu
Qunhong Wu
Background: Traditional “inverted triangle” healthcare resources allocation model in China has wasted a lot of health resources. The Chinese health reform began to strengthens the role of the primary health institutions in delivering primary health care especially in rural areas in the background of large development gap between urban-rural health and rapid growth in the incidence of chronic diseases in rural. We take hypertensive patients as an example, to verify the effect of policy implementation through distribution characteristics of rural primary health institutions preference of hypertensive patients and explore the influencing factor that promoting rationalized use of medical care for patients with chronic disease as well as rational allocation of health resources in rural areas. Methods: A cross-sectional survey was conducted in Heilongjiang, a province in northeastern China by using a self-designed questionnaire. Stratified cluster sampling was used to choose 484 hypertensive patients from two villages in Heilongjiang province in 2010. Results: About 88.4% of respondents reported preferred primary health institutions (83.5% preferred village clinics and 4.9% preferred township hospitals), 49.4% of respondents knew hypertension management administered by primary health institutions, 53.5% received hypertension education from primary care physicians, more than half of respondents reported that they didn’t receive telephone interviews and family visits from primary care physicians over the past 6 months. Residence closer to the primary health institutions (OR = 10.360), trust in village doctors (OR = 7.323), elders (OR = 3.001), and asked for return visits by primary health physicians (OR = 2.073) promote preferences for primary health institutions. Conclusions: Accessibility to primary healthcare and doctor-patient trust stimulate patients to choose the primary health institutions. Primary health institutions should improve general approach to hypertension management and enhance the ability of providing basic public health services.

6 August 2021 in Frontiers in Public Health
Verified
Journal Article
Open access
JWJiahui Wang
Jiahui Wang
XTXiao Tan
Xiao Tan
XQXinye Qi
Xinye Qi
XZXin Zhang
Xin Zhang
HLHuan Liu
Huan Liu
BIBykov Ilia
Bykov Ilia
Background: In moving toward universal health coverage in China, it is crucial to identify which populations should be prioritized for which interventions rather than blindly increasing welfare packages or capital investments. We identify the characteristics of vulnerable groups from multiple perspectives through estimating catastrophic health expenditure (CHE) and recommend intervention priorities.Methods: Data were from National Health Service Survey conducted in 2003, 2008, and 2013. According to the recommendation of WHO, this study adopted 40% as the CHE threshold. A binary regression was used to identify the determinants of CHE occurrence; a probit model was used to obtain CHE standardized incidence under the characteristics of single and two dimensions in 2013.Results: The total incidence of CHE in 2013 was 13.9%, which shows a general trend of growth from 2003 to 2013. Families in western and central regions and rural areas were more at risk. Factors related to social demography show that households with a female or an unmarried head of household or with a low socioeconomic status were more likely to experience CHE. Households with older adults aged 60 and above had 1,524 times higher likelihood of experiencing CHE. Among the health insurance schemes, the participants covered by the New Rural Cooperative Medical Scheme had the highest risk compared with the participants of all basic health insurance schemes. Households with several members seeking outpatient, inpatient care or with non-communicable diseases were more likely to experience CHE. Households with members not seeing a doctor or hospitalized despite the need for it were more likely to experience CHE. Characteristics such as a household head with characteristics related to low socioeconomic status, having more than two hospitalized family members, ranked high. Meanwhile, the combination of having illiterate household heads and with being covered by other health insurance plans or by none ranked the first place. Cancer notably caused a relatively high medical expenditure among households with CHE.Conclusion: In China, considering the vulnerability of the population across different dimensions is conducive to the alleviation of high CHE. Furthermore, people with multiple vulnerabilities should be prioritized for intervention. Identifying and targeting them to offer help and support will be an effective approach.

13 July 2022 in Tuberculosis and Lung Diseases
Verified
Journal Article
Open access
PDF file
IBI. A. Bykov
I. A. Bykov
The objective: to identify and systematize social and demographic risk factors for the development and spread of multiple drug resistant tuberculosis (MDR TB) in the Russian Federation (RF) by means of a systematic review of existing publications.Subjects and Methods. A systematic literature review was performed in accordance with the PRISMA criteria and included studies conducted in the Russian Federation from 2011 to 2021. Out of 2,861 publications, 26 studies were selected and analyzed.Results. According to the reviewed studies, patients with a history of incarceration, low income, unemployed, homeless, and patients suffering from alcohol and nicotine addiction are more susceptible to MDR TB. It was also found that MDR TB most often affected people of working age with a clear trend towards a younger cohort. The influence of such factors as gender and location on MDR TB risk is not clear due to conflicting data and comparative strength of evidence in publications.

13 March 2023 in Russian Rhinology
Verified
Journal Article
Closed access
VKV.E. Kokorina
V.E. Kokorina
IBI.A. Bykov
I.A. Bykov
ЦЕЛЬ ИССЛЕДОВАНИЯ Сравнительный анализ эффективности консервативных методик лечения медикаментозного ринита (МР), возникшего на фоне аллергического ринита (АР), с применением топических кортикостероидных препаратов (монопрепаратов и фиксированных комбинаций). ПАЦИЕНТЫ И МЕТОДЫ Обследованы 306 пациентов с диагнозом АР в соответствии с критериями международной программы ARIA и зависимостью от сосудосуживающих препаратов, возникшей на фоне отсутствия полного контроля над симптомами АР. Пациенты были разделены на три группы: в основной группе (102 пациента) в схемах лечения АР в сочетании с МР применяли фиксированную комбинацию мометазона фуроата и олопатадина гидрохлорида (Риалтрис); в группе контроля 1 (102 пациента) — фиксированную комбинацию мометазона фуроата и азеластина гидрохлорида; в группе контроля 2 (102 пациента) — монопрепарат мометазона фуроата. РЕЗУЛЬТАТЫ И ОБСУЖДЕНИЕ Скорость субъективного ощущения положительного эффекта от терапии (уменьшение ринореи и слезотечения, и улучшение носового дыхания) после первого использования препарата у пациентов основной группы составила 11,5 мин, в группе контроля 1 — 22 мин, в группе контроля 2 — 24 ч. Выраженный быстрый положительный эффект от фиксированных комбинаций способствовал более высокой приверженности терапии: 98% в основной группе, 87% в группе контроля 1 против 79% в группе монотерапии. Курс лечения в течение месяца позволил восстановить носовое дыхание с отказом от приема деконгестантов у 86 (83%) пациентов основной группы, в группах контроля 1 и 2 — у 79 (76%) и 68 (66%) больных соответственно. ВЫВОДЫ Фиксированная комбинация мометазона фуроата и олопатадина гидрохлорида в схемах лечения АР в сочетании с МР оказалась эффективнее на 17% в сравнении с монотерапией мометазоном фуроатом, что явилось статистически значимым (p=0,004, ОШ=0,38, ДИ 95% 0,19—0,74). При использовании фиксированной комбинации мометазона фуроата и азеластина гидрохлорида этот показатель не имел статистической значимости и составил 10% (p=0,063, ОШ=0,55, ДИ 95% 0,30—1,03).

10 November 2025 in Russian Bulletin of Otorhinolaryngology
Verified
Journal Article
Closed access
VKV.E. Kokorina
V.E. Kokorina
IBI.A. Bykov
I.A. Bykov
Allergic rhinitis (AR) leads not only to significant nasal obstruction and ocular symptoms but also, by affecting the entire respiratory epithelium, causes combined damage to the Eustachian tube and middle ear, resulting in exudative otitis media (EOM). To evaluate the clinical features of EOM of allergic origin and to compare treatment regimens targeting allergic inflammation — with the goal of restoring Eustachian tube function and middle ear drainage — 329 patients with confirmed allergic rhinitis were examined. Following otorhinolaryngological and audiological evaluations, pathology of the middle ear and Eustachian tube was identified in 51% of cases (168 individuals). Interestingly, 16% of these patients subjectively reported no hearing loss or sensation of ear fullness, despite objective confirmation of pathology. To assess the comparative effectiveness of different AR therapy regimens and their impact on middle ear and Eustachian tube pathology, the 168 affected patients were divided into four parallel groups: Main group (41 patients): treated with a fixed-dose combination of mometasone furoate and olopatadine hydrochloride (Rialtris); Control group 1 (45 patients): received intranasal monotherapy with mometasone furoate; Control group 2 (41 patients): treated with the oral antihistamine levocetirizine; Control group 3 (41 patients): received combination therapy of intranasal mometasone furoate and oral levocetirizine. To monitor the restoration of auditory tube function and middle ear pneumatization, tympanometry and micro-otoscopy were performed on days 1, 7, 14, and 30. All treatment regimens positively influenced Eustachian tube dysfunction. The combination of intranasal mometasone furoate and oral levocetirizine demonstrated superior efficacy, with a statistically significant difference (p=0.01, CO = –33.60; 95% CI –61.05 to –6.15). Due to the accelerated recovery of Eustachian tube function and restoration of its drainage capabilities, the need for invasive middle ear drainage procedures (e.g., shunting, tympanostomy) was eliminated in the group receiving the fixed intranasal combination of mometasone furoate and olopatadine hydrochloride. This fixed-dose combination appears to be the optimal treatment for allergic Eustachian tube dysfunction, owing to its direct endonasal action on the respiratory epithelium at the Eustachian tube, allowing for rapid restoration of middle ear ventilation.

3 March 2023 in Russian Bulletin of Otorhinolaryngology
Verified
Journal Article
Closed access
VKV.E. Kokorina
V.E. Kokorina
IBI.A. Bykov
I.A. Bykov
Фарингит является одним из проявлений SARS-CoV-2 и характеризуется специфическими изменениями фарингоскопической картины, длительным, волнообразным течением, усилением симптоматики после физической нагрузки и наличием показаний к проведению длительной топической терапии. ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить эффективность применения препарата «Тонзилгон Н» в схемах лечения тонзиллофарингита при инфекции, вызванной SARS-CoV-2, и влияние лечения на формирование постковидного синдрома. МАТЕРИАЛ И МЕТОДЫ В исследование включены 164 пациента с острым фарингитом, ассоциированным с SARS-CoV-2. В схеме лечения пациентов основной группы (n=81) применялся растительный лекарственный препарат «Тонзилгон Н» в форме капель для приема внутрь, в схеме лечения пациентов группы контроля (n=83) — бензидамина гидрохлорид в форме спрея для местного применения. Длительность наблюдения составила 21 сут с последующим осмотром в сроки более 12 нед после выздоровления для диагностики постковидного синдрома. РЕЗУЛЬТАТЫ У пациентов основной группы показана статистически значимая разница при оценке динамики купирования интенсивности боли в горле (p=0,002) и ощущения дискомфорта в глотке (p=0,004), однако при оценке оториноларингологом фарингоскопической картины статистически значимых различий между группами не было (p=0,558). Назначение препарата «Тонзилгон Н» снижает необходимость использования антибиотиков для лечения бактериальных осложнений SARS-CoV-2 более чем в 2,8 раза (p<0,001). При оценке безопасности терапии отмечено отсутствие влияния длительного приема препарата «Тонзилгон Н» на увеличение частоты побочных эффектов в виде аллергических реакций (p=0,311) и местных субъективных ощущений в виде жжения в глотке (p=0,849) у пациентов основной группы по сравнению с пациентами группы контроля. Формирование постковидного синдрома у пациентов основной группы наблюдалось в 3,3 раза реже по сравнению с пациентами группы контроля — 7,2% и 25,9% соответственно (p=0,001). ЗАКЛЮЧЕНИЕ Результаты исследования дают основание рекомендовать применение препарата «Тонзилгон Н» в лечении вирусного фарингита, ассоциированного с SARS-CoV-2, а также с целью профилактики постковидного синдрома.